ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy
08 mars 2024 08h30 HE
|
ReWalk Robotics Ltd. (DBA Lifeward)
Randomized clinical trial demonstrates significant improvements in walking ability for patients receiving therapy with the ReStore Exo-Suit as compared to a matched control group receiving...
Lifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may be considered
01 mars 2024 08h45 HE
|
ReWalk Robotics Ltd. (DBA Lifeward)
The decision was communicated through CMS’ bi-annual Healthcare Common Procedure Coding System (“HCPCS”) coding memorandum released yesterday; payment amount determination for ReWalk Personal...
Lifeward Reports Fourth Quarter and Full Year 2023 Financial Results
27 févr. 2024 08h00 HE
|
ReWalk Robotics Ltd. (DBA Lifeward)
Highest quarterly and annual revenue in the history of LifewardCommercial and operational integration complete; synergiesexpected to yield $3 million in annual net savings MARLBOROUGH, Mass. and...
Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024
20 févr. 2024 08h30 HE
|
ReWalk Robotics Ltd. (DBA Lifeward)
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Feb. 20, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward™), (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader...
ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward
29 janv. 2024 08h00 HE
|
ReWalk Robotics Ltd. (DBA Lifeward)
Lifeward brand reflects the Company’s commitment to pioneering innovative technology to empower the pursuit of life’s ambitions in the face of physical limitation or disability The complete...
ReWalk Robotics Expands Direct Sales Coverage to Canada
12 janv. 2024 08h30 HE
|
ReWalk Robotics Ltd.
MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Jan. 12, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading provider of innovative...
ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17
11 janv. 2024 17h00 HE
|
ReWalk Robotics Ltd.
MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Jan. 11, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) announced that Larry Jasinski, Chief...
First ReWalk Personal Exoskeleton Claim Paid by Medicare
05 janv. 2024 08h00 HE
|
ReWalk Robotics Ltd.
MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Jan. 05, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk”), a leading provider of innovative technologies that enable...
ReWalk Robotics CEO Issues Year-End 2023 Open Letter to Shareholders and Provides 2024 Commercial and Operational Priorities
04 janv. 2024 08h00 HE
|
ReWalk Robotics Ltd.
MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Jan. 04, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), today issued an open letter from Larry...
ReWalk Robotics Presents on Personal Exoskeleton Pricing at Medicare Public Meeting
30 nov. 2023 16h45 HE
|
ReWalk Robotics Ltd.
MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Nov. 30, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading provider of innovative...